Clinical Trials Directory

Trials / Completed

CompletedNCT01647997

Lactate Metabolism After an Endotoxin Challenge in Healthy Humans

Effects of an Acute Administration of Bacterial Endotoxin on Whole Body and Regional Lactate Metabolism in Healthy Male Volunteers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
14 (actual)
Sponsor
University of Lausanne · Academic / Other
Sex
Male
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

Sepsis is characterized by hyperlactatemia, the severity of which is proportionate with sepsis severity. The pathophysiological mechanisms (increased lactate production vs decreased lactate utilization; tissues involved in sepsis-induced lactate production) remain largely unknown. In this study, the investigators will assess whole body and regional metabolism in healthy young male subjects on two occasions, once after administration of an intravenous bacterial endotoxin challenge, and once without intervention. In one group of subjects, whole body lactate metabolism will be measured over 10 hours after the endotoxin challenge * Energy expenditure and net substrate oxidation rates (indirect calorimetry) * Lactate kinetics (measured by means of a continuous, exogenous sodium lactate infusion) * Glucose kinetics (measured with 6,6 d2 glucose) * Hemodynamic parameters and body temperature * Blood clinical chemistry In one group of subjects, whole body lactate metabolism will be measured over 10 hours after the endotoxin challenge * Energy expenditure and net substrate oxidation rates (indirect calorimetry) * Lactate kinetics (measured by means of a continuous, exogenous sodium lactate infusion) * Glucose kinetics (measured with 6,6 d2 glucose) * Hemodynamic parameters and body temperature * Blood clinical chemistry In a second group of subjects, regional muscle lactate metabolism will be measured over 10 hours after the endotoxin challenge by means of muscle microdialysis

Conditions

Interventions

TypeNameDescription
OTHERbacterial endotoxin challengeiv administration of 2ng/kg bacterial endotoxin

Timeline

Start date
2002-04-01
Primary completion
2004-03-01
Completion
2004-12-01
First posted
2012-07-24
Last updated
2012-07-24

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT01647997. Inclusion in this directory is not an endorsement.